MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GUPTA, R. S.
Right arrow Articles by SIMINOVITCH, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GUPTA, R. S.
Right arrow Articles by SIMINOVITCH, L.

Molecular Pharmacology, Vol 18, 136-143, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Structural Determinants Responsible for the Biological Activity of (-)-Emetine, (-)-Cryptopleurine, and (-)-Tylocrebrine: Structure-Activity Relationship among Related Compounds

RADHEY S. GUPTA 1, JIRI J. KREPINSKY 2, and LOUIS SIMINOVITCH 2

1 Departments of Medicine and Biochemistry, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
2 Department of Medical Genetics, University of Toronto, Toronto, Ontario, Canada M5S 1A8

The structural basis for the cross-resistance and the common site of action of the benzoiosoquinoline alkaloids, (-)-emetine, (-)-tubulosine, (-)-cephaeline, and (-)-dehydroemetine, and of the phenanthroquinolizidine-type alkaloids, (-)-cryptopleurine, and the phenanthroindolizidine type, (-)-tylocrebrine, has been investigated by examining the cross-resistance of emetine-resistant mutants of Chinese hamster ovary cells to a large number of related compounds. On the basis of our results, we suggest that the aforementioned compounds possess common structural determinants which are responsible for their biological activity and that the requirement for biological activity is a planar molecule with two aromatic rings (rendered slightly electron richer, i.e., electronegative by methoxyl or hydroxyl groups) and the presence of a nucleophilic element such as nitrogen at a certain distance from the aromatic rings. The structure-activity relationship between the compounds indicates that the distance between the two aromatic rings, the angle between the nitrogen atom and the rings, and the electronegative character of the rings and planarity of the structure are critical features in determining the biological activity. Based on a comparison between the structures of compounds of the emetine type and those that are phenanthrene based, we have proposed the absolute sterochemistry of (-)-cryptopoeurine and (-)-tylocrebnne.

Note:
ACKNOWLEDGMENTS The authors wish to thank Mr. David H. Chan for skillful technical assistance and Dr. B. Bosnich ofthe Chemistry Department (University of Toronto) for the circular dichroism measurements. We are also grateful to various investigators for providing us with the compounds employed here.

Submitted on November 16, 1979
Accepted on January 10, 1980




This article has been cited by other articles:


Home page
Cancer Res.Home page
N.-M. Chau, P. Rogers, W. Aherne, V. Carroll, I. Collins, E. McDonald, P. Workman, and M. Ashcroft
Identification of Novel Small Molecule Inhibitors of Hypoxia-Inducible Factor-1 That Differentially Block Hypoxia-Inducible Factor-1 Activity and Hypoxia-Inducible Factor-1{alpha} Induction in Response to Hypoxic Stress and Growth Factors
Cancer Res., June 1, 2005; 65(11): 4918 - 4928.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics